Basílio Flávia Machado Alves, Hammerschmidt Mariana, Mukai Maira Mitsue, Werner Betina, Pinheiro Rosângela Lameira, Moritz Sandra
Federal University of Paraná, Curitiba, PR, Brazil.
An Bras Dermatol. 2012 Sep-Oct;87(5):767-71. doi: 10.1590/s0365-05962012000500017.
Mucormycosis is an uncommon fungal infection caused by Mucorales. It frequently occurs in patients with neutropenia, diabetes, malignancy and on corticoid therapy. However, it is rare in patients with AIDS. Clinical disease can be manifested in several forms. The case reported illustrates the rare occurrence of chromoblastomycosis and mucormycosis in an immunosuppressed patient with multibacillary leprosy, under prolonged corticosteroid and thalidomide therapy to control leprosy type 2 reaction. Neutrophil dysfunction, thalidomide therapy and work activities are some of the risk factors in this case. Chromoblastomycosis was treated by surgical excision and mucormycosis with amphotericin B. Although the prognosis of mucormycosis is generally poor, in the reported case the patient recovered successfully. This case should alert dermatologists to possible opportunistic infections in immunosuppressed patients.
毛霉病是一种由毛霉目真菌引起的罕见真菌感染。它常发生于中性粒细胞减少、糖尿病、恶性肿瘤患者以及接受皮质类固醇治疗的患者中。然而,在艾滋病患者中较为罕见。临床疾病可表现为多种形式。所报道的病例说明了在一名患有多菌型麻风的免疫抑制患者中,在长期使用皮质类固醇和沙利度胺治疗以控制2型麻风反应的情况下,罕见地同时发生了着色芽生菌病和毛霉病。中性粒细胞功能障碍、沙利度胺治疗以及工作活动是该病例中的一些危险因素。着色芽生菌病通过手术切除治疗,毛霉病使用两性霉素B治疗。尽管毛霉病的总体预后通常较差,但在所报道的病例中患者成功康复。该病例应提醒皮肤科医生注意免疫抑制患者可能发生的机会性感染。